NEW YORK – Syapse said today that it has signed a research collaboration agreement with the US Food and Drug Administration's Oncology Center of Excellence to incorporate real-world evidence into regulatory decision-making. 

Under the multiyear agreement, Syapse will lend its technology to the OCE to help various FDA stakeholders find answers to regulatory questions about oncology testing and treatment patterns, drug dosing and safety, and patient outcomes.